Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Genetic Diseases, Inborn; Genetic Diseases, X-Linked; Muscular Diseases; Muscular Disorders, Atrophic; Muscular Dystrophies; Muscular Dystrophy, Duchenne; Nervous System Diseases; Neuromuscular Diseases Phase 2 ClinicalTrials
CONTENTS